Published in Am J Clin Nutr on July 01, 2005
High-dose folic acid supplementation effects on endothelial function and blood pressure in hypertensive patients: a meta-analysis of randomized controlled clinical trials. J Chiropr Med (2009) 0.88
Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine. Curr Pharmacogenomics Person Med (2011) 0.83
MTHFR C677T genotype and cardiovascular risk in a general population without mandatory folic acid fortification. Eur J Nutr (2014) 0.80
Meta-analysis of plasma homocysteine content and cognitive function in elderly patients with Alzheimer's disease and vascular dementia. Int J Clin Exp Med (2014) 0.78
Novel Approaches to Investigate One-Carbon Metabolism and Related B-Vitamins in Blood Pressure. Nutrients (2016) 0.75
Is there a causal role for homocysteine concentration in blood pressure? A Mendelian randomization study. Am J Clin Nutr (2015) 0.75
Effects of folic acid supplementation on serum homocysteine and lipoprotein (a) levels during pregnancy. Bioimpacts (2015) 0.75
Retracted Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. JAMA (2013) 4.88
Breaking up prolonged sitting reduces postprandial glucose and insulin responses. Diabetes Care (2012) 4.50
Diamonds sampled by plumes from the core-mantle boundary. Nature (2010) 3.52
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. Lancet (2004) 3.40
Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease. Arch Intern Med (2003) 2.68
HSP72 protects against obesity-induced insulin resistance. Proc Natl Acad Sci U S A (2008) 2.52
Similar effects of treatment on central and brachial blood pressures in older hypertensive subjects in the Second Australian National Blood Pressure Trial. Hypertension (2007) 2.13
Estimation of central aortic blood pressure: a systematic meta-analysis of available techniques. J Hypertens (2014) 2.10
Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy. Neuron (2012) 2.00
High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation (2009) 2.00
Brachial blood pressure but not carotid arterial waveforms predict cardiovascular events in elderly female hypertensives. Hypertension (2006) 1.90
Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion. JACC Cardiovasc Imaging (2012) 1.83
Insulin resistance and atherosclerosis. Endocr Rev (2006) 1.81
Retracted Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial. Ann Intern Med (2006) 1.71
Retracted Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. JAMA (2007) 1.69
Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque. Circ Res (2008) 1.65
Targeted reduction of advanced glycation improves renal function in obesity. Kidney Int (2011) 1.63
Low-renin hypertension with relative aldosterone excess is associated with impaired NO-mediated vasodilation. Hypertension (2005) 1.60
Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. J Am Coll Cardiol (2002) 1.58
Relaxin therapy reverses large artery remodeling and improves arterial compliance in senescent spontaneously hypertensive rats. Hypertension (2010) 1.58
Arterial stiffness and prediction of cardiovascular risk. J Hypertens (2002) 1.57
Large artery stiffness predicts ischemic threshold in patients with coronary artery disease. J Am Coll Cardiol (2002) 1.57
Retracted Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture. Hypertension (2005) 1.57
Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study. Int J Radiat Oncol Biol Phys (2010) 1.55
Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ Res (2003) 1.55
Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes. J Am Coll Cardiol (2009) 1.53
Mouse model of post-infarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology. Cardiovasc Res (2005) 1.52
Age and the treatment gap in the use of statins. Lancet (2003) 1.48
Plasma C-reactive protein, but not protein S, VCAM-1, von Willebrand factor or P-selectin, is associated with endothelium dysfunction in coronary artery disease. Atherosclerosis (2004) 1.43
Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux. Circulation (2009) 1.40
Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol (2011) 1.39
Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes (2012) 1.38
How health care reform will affect family physicians. Interview by Brandi White. Fam Pract Manag (2010) 1.38
Gender, sex hormones and autonomic nervous control of the cardiovascular system. Cardiovasc Res (2002) 1.38
Optimizing dosage of ketamine and xylazine in murine echocardiography. Clin Exp Pharmacol Physiol (2007) 1.31
Cardiovascular effects of relaxin: from basic science to clinical therapy. Nat Rev Cardiol (2009) 1.26
Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. J Mol Cell Cardiol (2007) 1.25
Effects of breaking up prolonged sitting on skeletal muscle gene expression. J Appl Physiol (1985) (2012) 1.24
High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation. Proc Natl Acad Sci U S A (2004) 1.23
Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression. Arterioscler Thromb Vasc Biol (2004) 1.23
Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammation. J Mol Cell Cardiol (2011) 1.22
Gender differences in artery wall biomechanical properties throughout life. J Hypertens (2011) 1.21
Gender differences in large artery stiffness pre- and post puberty. J Clin Endocrinol Metab (2003) 1.20
The emerging role of HDL in glucose metabolism. Nat Rev Endocrinol (2012) 1.17
Novel role of platelets in mediating inflammatory responses and ventricular rupture or remodeling following myocardial infarction. Arterioscler Thromb Vasc Biol (2011) 1.15
Advanced glycation end products are direct modulators of β-cell function. Diabetes (2011) 1.14
Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo. Life Sci (2007) 1.13
Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival. Cardiovasc Res (2006) 1.11
Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1. Mol Cell Endocrinol (2011) 1.11
Skeletal muscle nNOS mu protein content is increased by exercise training in humans. Am J Physiol Regul Integr Comp Physiol (2007) 1.10
Mechanism of cholesterol efflux in humans after infusion of reconstituted high-density lipoprotein. Eur Heart J (2011) 1.10
Influence of atrial fibrillation on microRNA expression profiles in left and right atria from patients with valvular heart disease. Physiol Genomics (2011) 1.10
Alternating bouts of sitting and standing attenuate postprandial glucose responses. Med Sci Sports Exerc (2014) 1.08
Sex steroids modulate human aortic smooth muscle cell matrix protein deposition and matrix metalloproteinase expression. Hypertension (2005) 1.08
Pathophysiological levels of soluble P-selectin mediate adhesion of leukocytes to the endothelium through Mac-1 activation. Circ Res (2008) 1.08
Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation. Am J Pathol (2009) 1.07
Metabolic phenotype of phosphoglucose isomerase mutants of Corynebacterium glutamicum. J Biotechnol (2003) 1.07
Misclassification of studies in 'Brachial artery tonometry and the Popeye phenomenon'. J Hypertens (2013) 1.07
Smaller aortic dimensions do not fully account for the greater pulse pressure in elderly female hypertensives. Hypertension (2008) 1.05
Fibrillin-1 genotype is associated with aortic stiffness and disease severity in patients with coronary artery disease. Circulation (2002) 1.05
Infarct size and post-infarct inflammation determine the risk of cardiac rupture in mice. Int J Cardiol (2009) 1.03
Accuracy of automated auscultatory blood pressure measurement during supine exercise and treadmill stress electrocardiogram-testing. Blood Press Monit (2004) 1.02
Physical fitness and reverse cholesterol transport. Arterioscler Thromb Vasc Biol (2004) 1.02
Usefulness of cooling and coronary catheterization to improve survival in out-of-hospital cardiac arrest. Am J Cardiol (2010) 1.01
Sex hormones and cardiomyopathic phenotype induced by cardiac beta 2-adrenergic receptor overexpression. Endocrinology (2003) 1.00
Assessment of cardiac function by echocardiography in conscious and anesthetized mice: importance of the autonomic nervous system and disease state. J Cardiovasc Pharmacol (2003) 1.00
Retracted Reduced arterial stiffness may contribute to angiotensin-converting enzyme inhibitor induced improvements in walking time in peripheral arterial disease patients. J Hypertens (2008) 0.98
Post-infarct cardiac rupture: recent insights on pathogenesis and therapeutic interventions. Pharmacol Ther (2012) 0.96
The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents. Am Heart J (2009) 0.96
Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention. Am J Cardiol (2011) 0.95
The value of magnetic resonance imaging in target volume delineation of base of tongue tumours--a study using flexible surface coils. Radiother Oncol (2010) 0.94
Effect of iron chelation on myocardial infarct size and oxidative stress in ST-elevation-myocardial infarction. Circ Cardiovasc Interv (2012) 0.94
Matrix metalloproteinase-3 and coronary remodelling: implications for unstable coronary disease. Cardiovasc Res (2007) 0.94
Assessment of central and peripheral arterial stiffness: studies indicating the need to use a combination of techniques. Am J Hypertens (2005) 0.93
Reconstituted high-density lipoprotein infusion modulates fatty acid metabolism in patients with type 2 diabetes mellitus. J Lipid Res (2011) 0.92
Macrophage migration inhibitory factor for the early prediction of infarct size. J Am Heart Assoc (2013) 0.92
Treatment accuracy of fractionated stereotactic radiotherapy. Radiother Oncol (2005) 0.91
Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis. Endocrinology (2007) 0.91
Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. Radiother Oncol (2006) 0.90
Large-artery stiffness contributes to the greater prevalence of systolic hypertension in elderly women. J Am Geriatr Soc (2004) 0.89
Activation of peripheral blood mononuclear cells and extracellular matrix and inflammatory gene profile in acute myocardial infarction. Clin Sci (Lond) (2010) 0.89
Effects of high-density lipoprotein elevation with cholesteryl ester transfer protein inhibition on insulin secretion. Circ Res (2013) 0.89
I(f) channel inhibitor ivabradine lowers heart rate in mice with enhanced sympathoadrenergic activities. Br J Pharmacol (2004) 0.88
Large artery stiffness is not related to plasma cholesterol in older subjects with hypertension. Arterioscler Thromb Vasc Biol (2004) 0.88
Plasma sphingosine-1-phosphate is elevated in obesity. PLoS One (2013) 0.88